Compare Abbisko Cayman Ltd. with Similar Stocks
Dashboard
1
Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 0.71%
- Poor long term growth as Net Sales has grown by an annual rate of 455.29% and Operating profit at 46.74% over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -124.12
2
Risky -
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-10.34%
0%
-10.34%
6 Months
-17.62%
0%
-17.62%
1 Year
164.13%
0%
164.13%
2 Years
449.17%
0%
449.17%
3 Years
276.57%
0%
276.57%
4 Years
123.39%
0%
123.39%
5 Years
0%
0%
0.0%
Abbisko Cayman Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
455.29%
EBIT Growth (5y)
46.74%
EBIT to Interest (avg)
-124.12
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.99
Sales to Capital Employed (avg)
0.15
Tax Ratio
63.87%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0.71%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
4.78
EV to EBIT
-118.47
EV to EBITDA
-128.16
EV to Capital Employed
1206.87
EV to Sales
NA
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-1018.73%
ROE (Latest)
-3.56%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
546.40
21.10
2,489.57%
Operating Profit (PBDIT) excl Other Income
2.10
-544.40
100.39%
Interest
1.70
2.40
-29.17%
Exceptional Items
-2.80
0.80
-450.00%
Consolidate Net Profit
30.70
-476.90
106.44%
Operating Profit Margin (Excl OI)
-42.80%
-26,814.10%
2,677.13%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 2,489.57% vs 0.00% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 106.44% vs 17.25% in Dec 2023
About Abbisko Cayman Ltd. 
Abbisko Cayman Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






